Metropolis Healthcare surges on executing pact to acquire 51% stake in Shraddha Diagnostic Centre

17 Jan 2020 Evaluate

Metropolis Healthcare is currently trading at Rs. 1666.00, up by 37.00 points or 2.27% from its previous closing of Rs. 1629.00 on the BSE.

The scrip opened at Rs. 1646.00 and has touched a high and low of Rs. 1669.00 and Rs. 1645.00 respectively. So far 332 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1719.70 on 14-Jan-2020 and a 52 week low of Rs. 904.85 on 14-May-2019.

Last one week high and low of the scrip stood at Rs. 1719.70 and Rs. 1609.15 respectively. The current market cap of the company is Rs. 8329.66 crore.

The promoters holding in the company stood at 57.41%, while Institutions and Non-Institutions held 21.62% and 20.97% respectively.

Metropolis Healthcare has executed Share Purchase and Shareholders' Agreement for the acquisition of 51% shareholding in Shraddha Diagnostic Centre (I). The purpose of the acquisition is to strengthen the presence of the company in the state of Gujarat, India.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.


Metropolis Health. Share Price

1923.30 -6.10 (-0.32%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×